Cargando…

Stress and drug resistance in cancer

Patients diagnosed with cancer often undergo considerable psychological distress, and the induction of the psychological stress response has been linked with a poor response to chemotherapy. The psychological stress response is mediated by fluctuations of the hormones glucocorticoids (GCs) and catec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flaherty, Renée L., Falcinelli, Marta, Flint, Melanie S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992509/ https://www.ncbi.nlm.nih.gov/pubmed/35582576 http://dx.doi.org/10.20517/cdr.2019.016

Ejemplares similares

Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer
por: Flaherty, Renée L., et al.
Publicado: (2017)

DNA damage as a result of psychological stress: implications for breast cancer
por: Flint, Melanie S, et al.
Publicado: (2012)

Drug resistance and combating drug resistance in cancer
por: Wang, Xuan, et al.
Publicado: (2019)

The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance
por: Xavier, Cristina P. R., et al.
Publicado: (2020)

Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems
por: Lainetti, Patrícia de Faria, et al.
Publicado: (2020)

Biologic Stress, Oxidative Stress, and Resistance to Drugs: What Is Hidden Behind
por: Pantelidou, Maria, et al.
Publicado: (2017)

Drug Resistance Driven by Cancer Stem Cells and Their Niche
por: Prieto-Vila, Marta, et al.
Publicado: (2017)

RET in breast cancer: pathogenic implications and mechanisms of drug resistance
por: Lo Nigro, Cristiana, et al.
Publicado: (2019)

Production and Characterization of Molecular Dications: Experimental and Theoretical Efforts
por: Falcinelli, Stefano, et al.
Publicado: (2020)

Tumour Microenvironment Stress Promotes the Development of Drug Resistance
por: Seebacher, Nicole A., et al.
Publicado: (2021)

Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma
por: Khaled, Jaafar, et al.
Publicado: (2022)

Modified Curcumins as Potential Drug Candidates for Breast Cancer: An Overview
por: Flint, Abigail L., et al.
Publicado: (2022)

An integrated framework for quantifying immune-tumour interactions in a 3D co-culture model
por: Al-Hity, Gheed, et al.
Publicado: (2021)

Caveolin-1, a stress-related oncotarget, in drug resistance
por: Wang, Zhiyu, et al.
Publicado: (2015)

Drug Resistance in Cancer: An Overview
por: Housman, Genevieve, et al.
Publicado: (2014)

Cancer Metabolism and Drug Resistance
por: Rahman, Mahbuba, et al.
Publicado: (2015)

Telomerase and drug resistance in cancer
por: Lipinska, Natalia, et al.
Publicado: (2017)

Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?
por: Szumilak, Marta, et al.
Publicado: (2021)

Learning the Ropes of Platelet Count Regulation: Inherited Thrombocytopenias
por: Bury, Loredana, et al.
Publicado: (2021)

Looking into Endoplasmic Reticulum Stress: The Key to Drug-Resistance of Multiple Myeloma?
por: Wang, Guangqi, et al.
Publicado: (2022)

Mechanisms of resistance to immune checkpoint inhibitors
por: Jenkins, Russell W, et al.
Publicado: (2018)

Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer
por: Benko, Aleksandra, et al.
Publicado: (2021)

Emerging targets in cancer drug resistance
por: Kumar, Shashank, et al.
Publicado: (2019)

Histone methyltransferase and drug resistance in cancers
por: Yang, Cheng, et al.
Publicado: (2020)

Drug resistance and Cancer stem cells
por: Li, Yuan, et al.
Publicado: (2021)

Drug resistance: from bacteria to cancer
por: Patel, Harsh, et al.
Publicado: (2021)

Nanomedicines for Overcoming Cancer Drug Resistance
por: Hu, Tingting, et al.
Publicado: (2022)

BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and Resistance
por: Sullivan, Ryan J., et al.
Publicado: (2011)

Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
por: Bahmad, Hisham F., et al.
Publicado: (2022)

Understanding Drug Sensitivity and Tackling Resistance in Cancer
por: Tyner, Jeffrey W., et al.
Publicado: (2022)

Role of Reductive versus Oxidative Stress in Tumor Progression and Anticancer Drug Resistance
por: Chun, Kyung-Soo, et al.
Publicado: (2021)

Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
por: Yi, Wenzhe, et al.
Publicado: (2023)

Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance
por: Nikesitch, Nicholas, et al.
Publicado: (2018)

Drug resistance and new therapies in colorectal cancer
por: Van der Jeught, Kevin, et al.
Publicado: (2018)

Aberrant RNA Splicing in Cancer and Drug Resistance
por: Wang, Bi-Dar, et al.
Publicado: (2018)

Genetic Influences in Breast Cancer Drug Resistance
por: Daniyal, Adhitiya, et al.
Publicado: (2021)

Ovarian cancer: epigenetics, drug resistance, and progression
por: Xie, Weiwei, et al.
Publicado: (2021)

The Hippo Signaling Pathway in Drug Resistance in Cancer
por: Zeng, Renya, et al.
Publicado: (2021)

Amino Acid Metabolism in Cancer Drug Resistance
por: Yoo, Hee-Chan, et al.
Publicado: (2022)

Cancer stem cells, plasticity, and drug resistance
por: Lionetti, Maria Chiara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nm0u2n83u0c8ujavtgei78iuvt